ReveraGen BioPharma Inc Initiates VISION-DMD Phase 2a Study for Treatment of Duchenne Muscular Dystrophy 08/09/2016 News
ECRIN Blog on Developing Standards for Describing Clinical Research Data Across Repositories 06/12/2016 News